These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29616326)

  • 41. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells.
    Boerman GH; van Ostaijen-ten Dam MM; Kraal KC; Santos SJ; Ball LM; Lankester AC; Schilham MW; Egeler RM; van Tol MJ
    Cancer Immunol Immunother; 2015 May; 64(5):573-83. PubMed ID: 25854581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
    Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
    Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lung natural killer cells play a major counter-regulatory role in pulmonary vascular hyperpermeability after myocardial infarction.
    Yan X; Hegab AE; Endo J; Anzai A; Matsuhashi T; Katsumata Y; Ito K; Yamamoto T; Betsuyaku T; Shinmura K; Shen W; Vivier E; Fukuda K; Sano M
    Circ Res; 2014 Feb; 114(4):637-49. PubMed ID: 24366170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Negative regulation of natural killer cell in tumor tissue and peripheral blood of oral squamous cell carcinoma.
    Dutta A; Banerjee A; Saikia N; Phookan J; Baruah MN; Baruah S
    Cytokine; 2015 Dec; 76(2):123-130. PubMed ID: 26372424
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural Killer Cells in the Lungs.
    Cong J; Wei H
    Front Immunol; 2019; 10():1416. PubMed ID: 31293580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selection and expansion of natural killer cells for NK cell-based immunotherapy.
    Becker PS; Suck G; Nowakowska P; Ullrich E; Seifried E; Bader P; Tonn T; Seidl C
    Cancer Immunol Immunother; 2016 Apr; 65(4):477-84. PubMed ID: 26810567
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural killer cells differentiated in vitro from cord blood CD34
    Domogala A; Blundell M; Thrasher A; Lowdell MW; Madrigal JA; Saudemont A
    Cytotherapy; 2017 Jun; 19(6):710-720. PubMed ID: 28428057
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impaired zeta chain expression and IFN-gamma production in peripheral blood T and NK cells of patients with advanced lung cancer.
    Ciszak L; Kosmaczewska A; Werynska B; Szteblich A; Jankowska R; Frydecka I
    Oncol Rep; 2009 Jan; 21(1):173-84. PubMed ID: 19082459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perioperative influenza vaccination reduces postoperative metastatic disease by reversing surgery-induced dysfunction in natural killer cells.
    Tai LH; Zhang J; Scott KJ; de Souza CT; Alkayyal AA; Ananth AA; Sahi S; Adair RA; Mahmoud AB; Sad S; Bell JC; Makrigiannis AP; Melcher AA; Auer RC
    Clin Cancer Res; 2013 Sep; 19(18):5104-15. PubMed ID: 23881927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transpresentation of interleukin-15 by IL-15/IL-15Rα mRNA-engineered human dendritic cells boosts antitumoral natural killer cell activity.
    Van den Bergh J; Willemen Y; Lion E; Van Acker H; De Reu H; Anguille S; Goossens H; Berneman Z; Van Tendeloo V; Smits E
    Oncotarget; 2015 Dec; 6(42):44123-33. PubMed ID: 26675759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice.
    Kozlowska AK; Kaur K; Topchyan P; Jewett A
    Cancer Immunol Immunother; 2016 Jul; 65(7):835-45. PubMed ID: 27034236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Activated natural killer cell-mediated immunity is required for the inhibition of tumor metastasis by dendritic cell vaccination.
    Kim A; Noh YW; Kim KD; Jang YS; Choe YK; Lim JS
    Exp Mol Med; 2004 Oct; 36(5):428-43. PubMed ID: 15557815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current Approaches to Engineering of NK Cells for Cancer Immunotherapy.
    Streltsova MA; Barsov EV; Erokhina SA; Sapozhnikov AM; Kovalenko EI
    Curr Pharm Des; 2018; 24(24):2810-2824. PubMed ID: 30156154
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Natural killer cells: In health and disease.
    Mandal A; Viswanathan C
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):47-55. PubMed ID: 25571788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An IL-12/Shh-C domain fusion protein-based IL-12 autocrine loop for sustained natural killer cell activation.
    Zhu L; Zhao Z; Wei Y; Marcotte W; Wagner TE; Yu X
    Int J Oncol; 2012 Aug; 41(2):661-9. PubMed ID: 22581115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
    Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
    Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of natural killer cells in the treatment of chronic myeloid leukemia.
    Silla LM; Whiteside TL; Ball ED
    J Hematother; 1995 Aug; 4(4):269-79. PubMed ID: 7489141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC; Weissler JC
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.